These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8261664)

  • 1. Interaction between circulating amyloid fibril protein precursors and extracellular tissue matrix components in the pathogenesis of systemic amyloidosis.
    Husby G; Stenstad T; Magnus JH; Sletten K; Nordvåg BY; Marhaug G
    Clin Immunol Immunopathol; 1994 Jan; 70(1):2-9. PubMed ID: 8261664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidosis.
    Husby G
    Semin Arthritis Rheum; 1992 Oct; 22(2):67-82. PubMed ID: 1439845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidosis: a clinico-pathophysiological synopsis.
    Hirschfield GM
    Semin Cell Dev Biol; 2004 Feb; 15(1):39-44. PubMed ID: 15036205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of amyloid proteins.
    Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
    Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidosis: new strategies for treatment.
    Hirschfield GM; Hawkins PN
    Int J Biochem Cell Biol; 2003 Dec; 35(12):1608-13. PubMed ID: 12962700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification of amyloidosis].
    Husby G
    Tidsskr Nor Laegeforen; 1996 Jan; 116(2):234-7. PubMed ID: 8633331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential significance of sulphated glycosaminoglycans as a common constituent of all amyloids: or, perhaps amyloid is not a misnomer.
    Kisilevsky R; Snow A
    Med Hypotheses; 1988 Aug; 26(4):231-6. PubMed ID: 3050385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.
    Snow AD; Wight TN
    Neurobiol Aging; 1989; 10(5):481-97. PubMed ID: 2682326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis and biochemistry of amyloidosis.
    Cohen AS; Connors LH
    J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.
    Sipe JD; Benson MD; Buxbaum JN; Ikeda SI; Merlini G; Saraiva MJ; Westermark P
    Amyloid; 2016 Dec; 23(4):209-213. PubMed ID: 27884064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidosis.
    Tan SY; Pepys MB
    Histopathology; 1994 Nov; 25(5):403-14. PubMed ID: 7868080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biochemical genetics of amyloid fibril proteins.
    Carbonara AO; Bottaro A
    Ric Clin Lab; 1989; 19(1):27-38. PubMed ID: 2669110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
    Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P
    Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A beta amyloidogenesis: unique, or variation on a systemic theme?
    Kisilevsky R; Fraser PE
    Crit Rev Biochem Mol Biol; 1997; 32(5):361-404. PubMed ID: 9383610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo.
    Annamalai K; Liberta F; Vielberg MT; Close W; Lilie H; Gührs KH; Schierhorn A; Koehler R; Schmidt A; Haupt C; Hegenbart U; Schönland S; Schmidt M; Groll M; Fändrich M
    Angew Chem Int Ed Engl; 2017 Jun; 56(26):7510-7514. PubMed ID: 28544119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
    Stenstad T; Magnus JH; Husby G
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amyloidosis and aging].
    Mimassi N; Youinou P; Pennec YL
    Ann Med Interne (Paris); 2002 Oct; 153(6):383-8. PubMed ID: 12486387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions.
    Borysik AJ; Morten IJ; Radford SE; Hewitt EW
    Kidney Int; 2007 Jul; 72(2):174-81. PubMed ID: 17495865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization of amyloid fibril precursors in renal tissue.
    Wagrowska-Danilewicz M; Danilewicz M
    Acta Histochem; 1996 Jul; 98(3):301-8. PubMed ID: 8863859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.